Prospective open uncontrolled phase I study to define a well-tolerated dose of oral artesunate as add-on therapy in patients with metastatic breast cancer (ARTIC M33/2)

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit et al. · International Journal of Cancer · 2014 · 29K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology

N.K. Aaronson, Sam H. Ahmedzai, Bengt Bergman et al. · JNCI Journal of the National Cancer Institute · 1993 · 16K citations

Pharmacy, Oncology, Cancer Symptom Management +15

The anti-malarial artesunate is also active against cancer

Thomas Efferth, Heather M. Dunstan, Axel Sauerbrey et al. · International Journal of Oncology · 2001 · 570 citations

Medicine, Medicinal Chemistry, Pharmacology +14

The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain

Klaus Linde, Claudia M. Witt, Andrea Streng et al. · Pain · 2007 · 553 citations

Medicine, Orthopaedic Surgery, Outcomes Research +14

Molecular Modes of Action of Artesunate in Tumor Cell Lines

Thomas Efferth, Axel Sauerbrey, Armin Olbrich et al. · Molecular Pharmacology · 2003 · 432 citations

Life Sciences, Oncology, Pharmacology +7